You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SDH-Mutant/Deficient

Showing 1 - 25 of 1,521
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumors, Sdh, GIST Trial in United States (Temozolomide)

Recruiting
  • Gastrointestinal Stromal Tumors
  • +3 more
  • La Jolla, California
  • +4 more
Aug 17, 2021

Gastrointestinal Stromal Tumors Trial in Seoul (Temozolomide capsule)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Temozolomide capsule
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Dec 14, 2022

Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

Not yet recruiting
  • Diffuse Astrocytoma, IDH-Mutant
  • +20 more
  • NEO212 Oral Capsule
  • +8 more
  • (no location specified)
Sep 18, 2023

Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in

Recruiting
  • Locally Advanced Gastrointestinal Stromal Tumor
  • +7 more
  • Biopsy
  • +4 more
  • Duarte, California
  • +17 more
Feb 2, 2023

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • (no location specified)
Jan 14, 2023

Type 1 Diabetes Trial in Ottawa (Social Navigator)

Not yet recruiting
  • Type 1 Diabetes
  • Social Navigator
  • Ottawa, Ontario, Canada
    Children's Hospital of Eastern Ontario - Research Institute
Jun 12, 2023

Locally Advanced Unresectable Breast Carcinoma, Metastatic Breast Carcinoma, Stage III Breast Cancer AJCC v7 Trial in United

Suspended
  • Locally Advanced Unresectable Breast Carcinoma
  • +3 more
  • Phoenix, Arizona
  • +57 more
Jul 27, 2022

TNBC - Triple-Negative Breast Cancer Trial in United States (Gedatolisib, Talazoparib)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Chicago, Illinois
  • +4 more
Jan 18, 2022

Endometrial Cancer Trial in Worldwide (drug, radiation, other)

Recruiting
  • Endometrial Cancer
  • Toronto, Canada
  • +5 more
Jul 12, 2022

Subdural Hematoma, Atrial Fibrillation Trial in Toronto (Direct Acting Oral Anticoagulant starting at Day 30, Direct Acting Oral

Not yet recruiting
  • Subdural Hematoma
  • Atrial Fibrillation
  • Direct Acting Oral Anticoagulant starting at Day 30
  • Direct Acting Oral Anticoagulant starting at Day 90
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
Jul 26, 2022

Subdural Hematoma Trial in Toronto (Tranexamic Acid 500 MG Oral Tablet, Tranexamic Acid 100 MG/ML, Tranexamic Acid 100 Mg/mL

Not yet recruiting
  • Subdural Hematoma
  • Tranexamic Acid 500 MG Oral Tablet
  • +3 more
  • Toronto, Ontario, Canada
    St. Michael's Hospital
Feb 9, 2023

Advance NSCLC Trial (GFH925, Cetuximab)

Not yet recruiting
  • Advance Non-small Cell Lung Cancer
  • (no location specified)
Mar 7, 2023

Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC

Recruiting
  • Non-small Cell Lung Cancer
    • Guanzhou, China
      Sun Yat-sen University Cancer Center
    Aug 11, 2023

    Subdural Hematoma Trial in Winnipeg MB (Embolization of the middle meningeal artery)

    Recruiting
    • Subdural Hematoma
    • Embolization of the middle meningeal artery
    • Winnipeg MB, Manitoba, Canada
      Health Sciences centre
    May 30, 2022

    NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

    Recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • +3 more
    • San Antonio, Texas
    • +1 more
    Sep 8, 2023

    Adolescent Idiopathic Scoliosis, Neuromuscular Scoliosis, Perioperative/Postoperative Complications Trial in New York (Oral

    Not yet recruiting
    • Adolescent Idiopathic Scoliosis
    • +6 more
    • Oral ferrous sulfate
    • Oral placebo tablet
    • New York, New York
      Columbia University Medical Center
    Sep 12, 2023

    Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)

    Not yet recruiting
    • Low Grade Glioma of Brain
    • PEPIDH1M vaccine + vorasidenib
    • Durham, North Carolina
      Duke University Medical Center
    Nov 2, 2022

    Burnout, Professional Trial in Winston-Salem (Tablet-based SDH tool)

    Completed
    • Burnout, Professional
    • Tablet-based SDH tool
    • Winston-Salem, North Carolina
    • +2 more
    Dec 17, 2021

    First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

    Completed
    • BRAF V600E Mutation Positive
    • Metastatic Colorectal Cancer
    • Non Interventional study
    • St. Veit/Glan, Austria
    • +33 more
    Jan 20, 2023

    Breast Cancer Trial (Empowerment and Navigation, SOC)

    Not yet recruiting
    • Breast Cancer
    • Empowerment and Navigation
    • SOC
    • (no location specified)
    Jul 29, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • San Francisco, California
      University of California, San Francisco
    Dec 6, 2022

    H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)

    Recruiting
    • H3 K27M
    • Glioma
    • Santa Monica, California
      Providence Saint John's Cancer Institute
    Nov 28, 2022

    Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Malignant Solid Neoplasm
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    Subdural Hematoma Trial in United States (procedure, device, other)

    Recruiting
    • Subdural Hematoma
    • Surgical Management
    • +3 more
    • Birmingham, Alabama
    • +26 more
    Mar 11, 2022

    CD55-deficient Protein-losing Enteropathy, CHAPLE Trial in Bethesda, Pathum Wan, Istanbul (Pozelimab)

    Active, not recruiting
    • CD55-deficient Protein-losing Enteropathy
    • CHAPLE
    • Bethesda, Maryland
    • +2 more
    Nov 8, 2022